| Karim J Salameh, MD | |
|
3300 Gallows Rd, Falls Church, VA 22042-3307 | |
| (703) 776-3111 | |
| (904) 346-0113 |
| Full Name | Karim J Salameh |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 3300 Gallows Rd, Falls Church, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518049360 | NPI | - | NPPES |
| P00370393 | Other | VA | RAILROAD MEDICARE |
| 1518049360 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 0101237845 (Virginia) | Primary |
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20040102000644 |
News Archive
A specially developed ‘smart indicator' technology from Timestrip is being adopted in developing countries where missed vaccinations are common.
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
Isotechnika Pharma Inc. announced today that Lux Biosciences, Inc. has commenced its pivotal Phase 3 trial using voclosporin for the treatment of non-infectious uveitis, a leading cause of vision loss and long-term disability.
In a study of cancer patients considering whether they should participate in phase I clinical trials, a high percentage were willing to participate after discussions with clinical staff, but nearly half thought that their tumors would shrink, which is much higher than what is realistically achieved.
WHO is calling on countries to be increasingly vigilant in monitoring antimalarial drug efficacy in order to allow for early detection of artemisinin resistance.1 This is one among several conclusions of the Global report on antimalarial drug efficacy and drug resistance: 2000-2010, released today. The report is based on 1100 studies conducted by national malaria control programs and research institutes over the ten-year period.
› Verified 1 days ago
| Entity Name | Emergency Medicine Associates Pa Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134117393 PECOS PAC ID: 8022914522 Enrollment ID: O20070919000389 |
News Archive
A specially developed ‘smart indicator' technology from Timestrip is being adopted in developing countries where missed vaccinations are common.
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
Isotechnika Pharma Inc. announced today that Lux Biosciences, Inc. has commenced its pivotal Phase 3 trial using voclosporin for the treatment of non-infectious uveitis, a leading cause of vision loss and long-term disability.
In a study of cancer patients considering whether they should participate in phase I clinical trials, a high percentage were willing to participate after discussions with clinical staff, but nearly half thought that their tumors would shrink, which is much higher than what is realistically achieved.
WHO is calling on countries to be increasingly vigilant in monitoring antimalarial drug efficacy in order to allow for early detection of artemisinin resistance.1 This is one among several conclusions of the Global report on antimalarial drug efficacy and drug resistance: 2000-2010, released today. The report is based on 1100 studies conducted by national malaria control programs and research institutes over the ten-year period.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karim J Salameh, MD Po Box 759101, Baltimore, MD 21275-0001 Ph: (703) 205-9790 | Karim J Salameh, MD 3300 Gallows Rd, Falls Church, VA 22042-3307 Ph: (703) 776-3111 |
News Archive
A specially developed ‘smart indicator' technology from Timestrip is being adopted in developing countries where missed vaccinations are common.
Bristol-Myers Squibb and Otsuka Pharmaceutical have announced that the U.S. Food and Drug Administration (FDA) has approved Abilify (aripiprazole) for the treatment of acute bipolar mania, including manic and mixed episodes associated with bipolar disorder.
Isotechnika Pharma Inc. announced today that Lux Biosciences, Inc. has commenced its pivotal Phase 3 trial using voclosporin for the treatment of non-infectious uveitis, a leading cause of vision loss and long-term disability.
In a study of cancer patients considering whether they should participate in phase I clinical trials, a high percentage were willing to participate after discussions with clinical staff, but nearly half thought that their tumors would shrink, which is much higher than what is realistically achieved.
WHO is calling on countries to be increasingly vigilant in monitoring antimalarial drug efficacy in order to allow for early detection of artemisinin resistance.1 This is one among several conclusions of the Global report on antimalarial drug efficacy and drug resistance: 2000-2010, released today. The report is based on 1100 studies conducted by national malaria control programs and research institutes over the ten-year period.
› Verified 1 days ago
Dr. Andrew Lewis Miner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Emergency Department, Falls Church, VA 22042 Phone: 703-776-3195 Fax: 703-776-2893 | |
Vasilios Dimitrios Mavrophilipos, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd Dept Of, Falls Church, VA 22042 Phone: 703-776-4001 | |
Robert Glen Solberg, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-2690 Fax: 703-776-2893 | |
Rodolfo Lopez, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3111 Fax: 800-536-8431 | |
Scott D Weir, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3111 Fax: 800-536-8431 | |
Robert Cates, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3111 Fax: 904-346-0113 | |
Konstantinos Kohilas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3300 Gallows Rd, Falls Church, VA 22042 Phone: 703-776-3111 Fax: 800-536-8431 |